Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
21
2024
FDA Publishes Paper Detailing Actions It Intends to Take Regarding the Uses of AI Across the Medical Product Life Cycle Nelson Mullins
Mar
21
2024
Specially Convened Rehearing Panel Vacates IPR Institution Denial McDermott Will & Emery
Mar
21
2024
Legalizing LSD? FDA Says Mm-hmm to MM120 Bradley Arant Boult Cummings LLP
Mar
20
2024
Medicare Changes to Make Drug Coverage More Manageable in 2025 Polsinelli PC
Mar
20
2024
2024 Litigation Look Ahead Series: Key Cases That Could Impact CERCLA Liability and Contribution Claims Beveridge & Diamond PC
Mar
20
2024
FDA Issues Import Alert for Food Products Containing Chemical Contaminants including PFAS Keller and Heckman LLP
Mar
20
2024
Canada Grants its First Approval for Animal-Free Milk Protein Keller and Heckman LLP
Mar
20
2024
Synchronizing with Cyborgs: Who Am I – Human or Machine? Nishith Desai Associates
Mar
20
2024
FDA Releases Draft Guidance on New Dietary Ingredient Notification Procedures, Timelines Epstein Becker & Green, P.C.
Mar
19
2024
Behavioral Health M&A 2024 Legal Trends Polsinelli PC
Mar
19
2024
TTB Ramps Up Tax Audits and Enforcement McDermott Will & Emery
Mar
19
2024
Time to Refresh? FDA Issues Draft Guidance on Key Information and Informed Consent Sheppard, Mullin, Richter & Hampton LLP
Mar
19
2024
GT Legal Food Talk Episode 24: Tracking Top Food & Beverage Trends in 2024 [Podcast] Greenberg Traurig, LLP
Mar
19
2024
Veep Urges DEA to Reschedule Marijuana “As Quickly as Possible” Bradley Arant Boult Cummings LLP
Mar
19
2024
Food Industry Group Files Brief in Support of GMO Labeling Rule Keller and Heckman LLP
Mar
19
2024
FDA and OHRP Issue Joint Draft Guidance on Content, Organization, and Presentation of Consent Forms for Research Participants Epstein Becker & Green, P.C.
Mar
18
2024
Cadwalader Climate (March 18, 2024) Cadwalader, Wickersham & Taft LLP
Mar
18
2024
China Announces the Standard for Food Packaging Adhesives Keller and Heckman LLP
Mar
18
2024
Nevada Supreme Court Reverses $48 Million Verdict, Concludes Hospitals Do Not Owe Fiduciary Duty to Patients in the Provision of Medical Services Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
15
2024
Recent Federal Developments for March 2024 Bergeson & Campbell, P.C.
Mar
15
2024
China Announces the Standard for Food-Contact Adhesives Keller and Heckman LLP
Mar
15
2024
USDA FSIS Final Rule for Voluntary “Product of the USA” Claims Keller and Heckman LLP
Mar
14
2024
Clinical Research: FDA Issues Draft Guidance on Informed Consent Foley & Lardner LLP
Mar
14
2024
Optimizing Obviousness: Routine Optimization Can Fill in Prior Art Gaps McDermott Will & Emery
Mar
14
2024
My Healthy Food Product is Ready to Go to Market – What About its Packaging? Foley & Lardner LLP
Mar
14
2024
Draft European Commission Proposal May Significantly Impact Plastic Food-Contact Materials Keller and Heckman LLP
Mar
13
2024
White House OSTP Posts Readout of NNI Symposium Celebrating 20th Anniversary of the 21st Century Nanotechnology R&D Act Bergeson & Campbell, P.C.
Mar
13
2024
Clinical Trials: FDA Issues Finalized Charging Guidance for Investigational Drug Use Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins